A federal grand jury's price fixing charges against Ara Aprahamian, a former generic pharma executive, are based on discussions he had with cooperating witnesses at an unnamed competitor firm. While the indictment does not name Aprahmian's former company, it is clear from the details provided that it is Taro Pharmaceuticals USA Inc.
The indictment, issued on 4 February, charges Aprahamian, Taro's former VP of Sales and Marketing, with participating in two...





